Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2020 | Story Ruan Bruwer | Photo Gallo Images
Three Kovsies in Springbok coaching team
Rassie Erasmus (left), director of rugby at the South African Rugby Union, congratulates Jacques Nienaber on being the new Springbok head coach, the position Erasmus previously filled. Both are former students of the University of the Free State.

The appointment of Jacques Nienaber as the new Springbok head coach means that a former Kovsie will once again coach the Springbok team. Nienaber takes over from Rassie Erasmus, another Kovsie alumnus.

It was also announced that Daan Human, like Erasmus a former Shimla player who went on to play for the Springboks, will be the scrum consultant. Erasmus will continue in the role of director of rugby and will be part of the Springbok coaching team, which means that half of the six coaches in the team can call themselves Kovsies. 

Nienaber joined Erasmus in the Springbok coaching team in February 2018 as defensive coach. At the 2019 Rugby World Cup, the Springboks conceded the fewest tries (four) of all the teams. Erasmus will be responsible for the strategy and results, with Nienaber taking operational control. 

It will be the first time Nienaber steps into a head-coach role. He started as physiotherapist with the Shimlas U20 team, before going into strength and conditioning and later becoming a defence coach.“This is a massive honour and responsibility, but I think I have a good understanding of what it entails, especially in this new structure. It’s a big step-up for me. I would not have accepted if I didn’t believe I could be successful,” said the 47-year-old Nienaber.

“I’ve been worked with Rassie in a coaching capacity for nearly two decades now and we have a very good idea of how each of us thinks.” The two first worked together in the Shimlas U20 team, where Erasmus was the captain and Nienaber the physio.

Besides Nienaber, two other former Shimlas are currently in a head-coach role – Neil Powell at the Springbok Sevens team and Franco Smith is coaching the Italian national team.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept